These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 7820568)

  • 1. Patterns of oligodendroglia pathology in multiple sclerosis.
    Ozawa K; Suchanek G; Breitschopf H; Brück W; Budka H; Jellinger K; Lassmann H
    Brain; 1994 Dec; 117 ( Pt 6)():1311-22. PubMed ID: 7820568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligodendrocytes in the early course of multiple sclerosis.
    Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
    Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.
    Lucchinetti C; Brück W; Parisi J; Scheithauer B; Rodriguez M; Lassmann H
    Brain; 1999 Dec; 122 ( Pt 12)():2279-95. PubMed ID: 10581222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.
    Lassmann H; Suchanek G; Ozawa K
    Ann Neurol; 1994; 36 Suppl():S42-6. PubMed ID: 8017888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology in multiple sclerosis: new concepts.
    Lassmann H
    Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocyte injury is an early event in lesions of multiple sclerosis.
    Rodriguez M; Scheithauer BW; Forbes G; Kelly PJ
    Mayo Clin Proc; 1993 Jul; 68(7):627-36. PubMed ID: 8350635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions.
    Mews I; Bergmann M; Bunkowski S; Gullotta F; Brück W
    Mult Scler; 1998 Apr; 4(2):55-62. PubMed ID: 9599334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis.
    Lucchinetti CF; Brück W; Rodriguez M; Lassmann H
    Brain Pathol; 1996 Jul; 6(3):259-74. PubMed ID: 8864283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
    Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
    Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remyelination in multiple sclerosis.
    Lassmann H; Brück W; Lucchinetti C; Rodriguez M
    Mult Scler; 1997 Apr; 3(2):133-6. PubMed ID: 9291167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions.
    Prineas JW; Kwon EE; Goldenberg PZ; Cho ES; Sharer LR
    Lab Invest; 1990 Nov; 63(5):624-36. PubMed ID: 1700195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation stimulates remyelination in areas of chronic demyelination.
    Foote AK; Blakemore WF
    Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructure of multiple sclerosis.
    Rodriguez M; Scheithauer B
    Ultrastruct Pathol; 1994; 18(1-2):3-13. PubMed ID: 8191643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin regulatory factor drives remyelination in multiple sclerosis.
    Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
    Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.
    Lucchinetti CF; Mandler RN; McGavern D; Bruck W; Gleich G; Ransohoff RM; Trebst C; Weinshenker B; Wingerchuk D; Parisi JE; Lassmann H
    Brain; 2002 Jul; 125(Pt 7):1450-61. PubMed ID: 12076996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.
    Chang A; Tourtellotte WW; Rudick R; Trapp BD
    N Engl J Med; 2002 Jan; 346(3):165-73. PubMed ID: 11796850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
    Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
    Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical remyelination: a new target for repair therapies in multiple sclerosis.
    Chang A; Staugaitis SM; Dutta R; Batt CE; Easley KE; Chomyk AM; Yong VW; Fox RJ; Kidd GJ; Trapp BD
    Ann Neurol; 2012 Dec; 72(6):918-26. PubMed ID: 23076662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.